Macrophage-Membrane-Coated Nanoparticles for Tumor-Targeted Chemotherapy

Nano Lett. 2018 Mar 14;18(3):1908-1915. doi: 10.1021/acs.nanolett.7b05263. Epub 2018 Feb 23.

Abstract

Various delivery vectors have been integrated within biologically derived membrane systems to extend their residential time and reduce their reticuloendothelial system (RES) clearance during systemic circulation. However, rational design is still needed to further improve the in situ penetration efficiency of chemo-drug-loaded membrane delivery-system formulations and their release profiles at the tumor site. Here, a macrophage-membrane-coated nanoparticle is developed for tumor-targeted chemotherapy delivery with a controlled release profile in response to tumor microenvironment stimuli. Upon fulfilling its mission of tumor homing and RES evasion, the macrophage-membrane coating can be shed via morphological changes driven by extracellular microenvironment stimuli. The nanoparticles discharged from the outer membrane coating show penetration efficiency enhanced by their size advantage and surface modifications. After internalization by the tumor cells, the loaded drug is quickly released from the nanoparticles in response to the endosome pH. The designed macrophage-membrane-coated nanoparticle (cskc-PPiP/PTX@Ma) exhibits an enhanced therapeutic effect inherited from both membrane-derived tumor homing and step-by-step controlled drug release. Thus, the combination of a biomimetic cell membrane and a cascade-responsive polymeric nanoparticle embodies an effective drug delivery system tailored to the tumor microenvironment.

Keywords: biomimetic delivery system; breast-cancer targeting; cascade-responsiveness; macrophage-membrane coating; tumor microenvironment.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Antineoplastic Agents, Phytogenic / administration & dosage*
  • Antineoplastic Agents, Phytogenic / pharmacokinetics
  • Antineoplastic Agents, Phytogenic / therapeutic use
  • Biomimetic Materials / metabolism
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / metabolism
  • Breast Neoplasms / pathology
  • Cell Line, Tumor
  • Cell Membrane / metabolism*
  • Delayed-Action Preparations / metabolism*
  • Drug Delivery Systems
  • Female
  • Humans
  • Macrophages / metabolism*
  • Mice
  • Nanoparticles / metabolism*
  • Nanoparticles / ultrastructure
  • Paclitaxel / administration & dosage*
  • Paclitaxel / pharmacokinetics
  • Paclitaxel / therapeutic use
  • Tumor Microenvironment / drug effects

Substances

  • Antineoplastic Agents, Phytogenic
  • Delayed-Action Preparations
  • Paclitaxel